L&K Biomed's Spinal Implant 'Yochu Plate'... Approved by US FDA

[Asia Economy Reporter Hyunseok Yoo] L&K Biomed announced on the 29th that its lumbar plate, one of the spinal implants (product name Accelfix-LP), has received approval from the U.S. Food and Drug Administration (FDA).

L&K Biomed already holds FDA approval for fixation screws and interbody cages. With the FDA approval of the lumbar plate, the company explained that it has secured the entire product lineup of spinal implants used in the lumbar region, thereby solidifying its position as a specialized spinal implant company.

The lumbar plate is a representative spinal implant used in spinal fusion surgery, along with fixation screws that stabilize adjacent vertebrae and interbody cages that serve the role of the intervertebral disc.

Spinal fusion surgery has long been one of the treatment methods for severe spinal diseases. The surgery involves fixing adjacent vertebral bodies to prevent movement or removing the intervertebral disc and inserting a cage to fuse the adjacent vertebrae. Spinal diseases are increasing worldwide, including in South Korea, due to the aging population and rising obesity rates, and accordingly, the spinal implant market is rapidly growing.

The lumbar plate functions to prevent the displacement of the interbody cage while also stabilizing the relative positions of the vertebrae. It promotes bone growth, which can improve surgical outcomes. The FDA-approved lumbar plate can be used in surgeries employing the anterior approach, lateral approach, and oblique lateral approach.

Recently, the spinal implant market trend is gradually moving away from the traditional posterior approach. The lateral approach, which is a safe and effective surgical method, is emerging as a new leader. A company official stated, "The launch of the lumbar plate will build a lineup together with Accelfix-XL, an FDA-approved expandable lateral cage for the lateral approach already available in the U.S. market," adding, "This is expected to create significant synergy effects for L&K Biomed's sales growth."

This content was produced with the assistance of AI translation services.